The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

A new study has found that patients with type 2 diabetes who are not reaching their blood sugar goals on dulaglutide can ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

A study by the Johns Hopkins Bloomberg School of Public Health found a significant increase in the use of these drugs among people with type 1 diabetes, despite limited safety and effectiveness ...